Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors
|Disease Area:||Lung Cancer|
|Application:||Disease therapy development|
|Biological Endpoints:||Gene expression|
|Throughput:||Not relevant (e.g. In silico)|
|Authors:||Brant, R. - Sharpe, A. - Liptrot, T. - Dry, JR. - Harrington, EA. - Barrett, JC. - Whalley, N. - Womack, C. - Smith, P. - Hodgson, DR.|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.